Labarin da aka bayar ta Business Wire a harshen Faransanci ya bayyana cewa Ofishin Patent da Alamun Kasuwanci na Amurka (USPTO) ya soke wani patent da kamfanin Pharmacyclics ya yi ikirari a kan kamfanin BeiGene. A takaice dai, an ce Pharmacyclics ya yi kokarin kare wani kirkire-kirkire ta hanyar patent a kan BeiGene, amma hukumar Amurka mai kula da patent ta ce patent din ba shi da tushe, don haka ta soke shi. Wannan na nufin BeiGene ba za ta fuskanci shari’a ko hana ta yin amfani da fasahar da Pharmacyclics ke ikirarin mallaka ba a Amurka.
AI ta bayar da labari.
An yi amfani da tambayar mai zuwa don samar da amsa daga Google Gemini:
A 2025-05-01 03:56, ‘L'Office des brevets et des marques des États-Unis invalide un brevet de Pharmacyclics revendiqué contre BeiGene’ an rubuta bisa ga Business Wire French Language News. Da fatan za a rubuta cikakken bayani mai saukin fahimta. Da fatan za a amsa a cikin Hausa.
1984